3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
9
Pancreatic Neoplasms
8
Rectal Neoplasms
5
Urinary Bladder Neoplasms
4
Stomach Neoplasms
4
Colonic Neoplasms
3
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Clinical Stage I Gastric Cancer AJCC v8
2
Cholangiocarcinoma
2
Appendiceal Neoplasms
2
Anus Neoplasms
2
Uterine Neoplasms
1
Tongue Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Salivary Gland Neoplasms
1
Peritoneal Neoplasms
1
Paranasal Sinus Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Adenocarcinoma
1
PRETEXT I Hepatoblastoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Metastatic Small Intestinal Adenocarcinoma
1
Lymphoid Interstitial Pneumonia
1
Laryngeal Neoplasms
1
Interventions
pembrolizumab
44
Gemcitabine
23
enfortumab vedotin
21
Nivolumab
20
Cisplatin
17
avelumab
16
Magnetic Resonance Spectroscopy
15
Carboplatin
14
atezolizumab
13
Specimen Handling
12
Docetaxel
11
sacituzumab govitecan
9
Paclitaxel
8
Ipilimumab
8
durvalumab
6
Mitomycin
5
Fluorodeoxyglucose F18
5
cabozantinib
4
Taxes
4
toripalimab
3
pemigatinib
3
erdafitinib
3
X-Rays
3
Radiosurgery
3
Platinum
3
Pemetrexed
3
Immunoglobulin G
3
CTLA-4 Antigen
3
Biopsy
3
ALT-803
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
dehydroftorafur
×
1 year
×
Clear all
No trials found.